FDA Approves First Biosimilar Drug for Treatment of Wet AMD

Posted on November 29, 2021November 29, 2021 by Dan Roberts

November 29, 2021

FDA Approves First Biosimilar Drug for Treatment of Wet AMD

The U.S. Food and Drug Administration (FDA) has approved Byooviz (ranibizumab-nuna) as the first biosimilar to Lucentis (ranibizumab injection) for the treatment of wet AMD. Byooviz is also approved to treat macular edema and myopic choroidal neovascularization, a vision-threatening complication of myopia (nearsightedness). The drug is administered by intravitreal injection (delivered into the vitreous humor […]

Also posted in

Latest News
Therapies, Treatments, and Procedures

FDA Approves Genentech’s Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration (AMD)

Posted on October 22, 2021April 2, 2022 by Dan Roberts

October 22, 2021

FDA Approves Genentech’s Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration (AMD)

Susvimo, previously called Port Delivery System with ranibizumab, is the first wet AMD treatment in 15 years to provide an alternative to standard-of-care eye injections needed as often as once a month. By continuously delivering medicine into the eye through a refillable implant, Susvimo may help people with wet AMD maintain their vision with as […]

Also posted in

Latest News
Therapies, Treatments, and Procedures

Port Delivery System Under Priority Review by FDA

Posted on June 24, 2021April 2, 2022 by Dan Roberts

June 24, 2021

Port Delivery System Under Priority Review by FDA

Frequent Eye Injections May Soon Be History Genentech Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) is giving priority review for the company’s Port Delivery System for the treatment of wet age-related macular degeneration (AMD). If approved, PDS will be a first-of-its-kind therapeutic approach, offering people living with wet AMD an alternative […]

Also posted in

Latest News
Research and Developments

Rising Above COVID19 Depression

Posted on June 20, 2021June 20, 2021 by Dan Roberts

June 20, 2021

Rising Above COVID19 Depression

Prevalence of all forms of depression during the COVID19 pandemic was found to be 20% in a study population of 113,285 individuals.(1) Not unexpectedly, this is higher than the pre-pandemic rate. Compounded with already high levels of depression among those who are socially isolated due to visual impairment (2), this gives cause for increased concern […]

Also posted in

Age-Reversal Diet and Lifestyle Plan May Slow AMD Development

Posted on June 11, 2021June 13, 2021 by Dan Roberts

June 11, 2021

Age-Reversal Diet and Lifestyle Plan May Slow AMD Development

Several studies have identified specific nutrients and healthy behaviors as effective in delaying the development and slowing the progression of age-related diseases like macular degeneration. It has been said that the best cure for age-related macular degeneration (AMD) is to simply stop growing older. Now a pilot study of 43 men ages 50 to 72 […]

Also posted in

Health and Nutrition
Latest News

News & Archive Categories

Category: Latest News

FDA Approves First Biosimilar Drug for Treatment of Wet AMD